oasis 1 oral semaglutide 50 mg nejm 2023 obesity at a Dose of 25 in Adults with Overweight or oral semaglutide 50 mg obesity

While structurally related PT-141 is a metabolite derived from Melanotan II the two peptides differ fundamentally in their molecular architecture: Melanotan II is a cyclic heptapeptide containing a lactam bridge, while PT-141 is a linear heptapeptide lacking this cyclization

Also available is Foundayo, an advanced oral GLP-1 variant offering intake flexibility, sans food or water limitations

Silico Pharmacol

References: Prevalence and incidence of shoulder pain in the general population

In August 2025, Adia Med announced its entry into the USD 1.9 billion glutathione market through the launch of innovative IV glutathione therapies and Glutaryl Transdermal Glutathione Spray